Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
Three Democrats are seeking information from tech firms about the growing energy use of data centers and the utility bills of individuals and other businesses. By Ivan Penn and Karen Weise Three ...
Abstract: This brief presents a novel compute-SRAM bitcell design capable of performing 1-bit digital multiplication for digital compute-in-memory (DCIM) macros. Unlike the conventional approach, ...
Pioneer Innovates Beyond Mobile EV Charging, Debuts PRYMUS for Rapid Mobile Distributed Power Package Delivery FORT LEE, N.J.--(BUSINESS WIRE)-- Pioneer Power Solutions, Inc. (PPSI) (“Pioneer” or the ...
Abstract: Perpendicularly magnetization magnetic tunnel junctions (p-MTJs) comprising heavy metals (HMs) and topological insulators (TIs) as spin-source materials are employed to achieve field-free ...
Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...
'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Grandfather, 3-month-old granddaughter dead after violent dog attack Opinion: Why Marjorie ...
Navarro and Harrison Fields got into a heated clash on CNN over the topic of drugs entering the United States: "You are wrong, and you are lying to the American people." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback